RxDoctor Payments DataLook up a doctor →

Laura Porch

Family · Cordova, TNNPI 1487609509

Payments from drug & device makers

$148,007in general payments, 2019–2025

Across 1,635 payments — averaging $90.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Neurocrine Biosciences, Inc.$59K
  • AbbVie$36K
  • Lundbeck LLC$10K
  • Amneal Pharmaceuticals LLC$10K
  • Livanova USA, Inc.$7K
  • Abbott$3K
  • plus $22K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Neurocrine Biosciences, Inc.154$59,166
AbbVie(2 entities)291$36,348
Lundbeck LLC50$10,085
Amneal Pharmaceuticals LLC83$9,647
Livanova USA, Inc.24$7,334
Abbott25$3,347
Novartis103$2,875
Boston Scientific11$2,156
MDD US Operations, LLC22$1,864
Amgen(2 entities)79$1,349
Pfizer102$1,059
UCB, Inc.41$975
EMD Serono, Inc.52$931
Biogen44$758
Argenx US, Inc.34$718
Teva Pharmaceuticals USA, Inc.58$709
AstraZeneca(2 entities)26$678
Bristol Myers Squibb42$658
TG Therapeutics, Inc.25$593
Genentech USA, Inc.36$586
Lilly USA, LLC32$478
Acadia Pharmaceuticals Inc30$468
Eisai Inc.22$468
SK Life Science, Inc.29$468
Otsuka America Pharmaceutical, Inc.22$332
Medtronic6$332
Neurelis, Inc.11$271
Alnylam Pharmaceuticals Inc.14$255
Grifols USA, LLC13$254
Harmony Biosciences LLC10$250
CSL Behring12$214
Biohaven Pharmaceutical Holding Company Ltd.15$207
Axsome Therapeutics, Inc.4$201
Acorda Therapeutics, Inc10$182
C2n Diagnostics, LLC8$140
Biohaven Pharmaceuticals, Inc.10$134
Jazz Pharmaceuticals Inc.6$124
Banner Life Sciences, LLC8$122
Sanofi5$108
Sunovion Pharmaceuticals Inc.8$99
Tanabe Pharma America, Inc.6$94
Johnson & Johnson(2 entities)4$92
Adamas Pharmaceuticals, Inc.4$90
Avanir Pharmaceuticals, Inc.5$87
Scilex Pharmaceuticals Inc.4$69
Insightec,inc1$67
Mallinckrodt Hospital Products Inc.3$55
Merz Pharmaceuticals, LLC2$51
Ipsen Biopharmaceuticals, Inc2$41
Catalyst Pharmaceuticals, Inc.2$39
ANI Pharmaceuticals, Inc.2$36
Kyowa Kirin, Inc.2$36
Akcea Therapeutics, Inc.2$30
Cycle Pharmaceuticals Inc2$28
Takeda Pharmaceuticals U.S.A., Inc.1$23
Nevro Corp.1$23
Averitas Pharma Inc.1$20
Sanofi-aventis U.S. LLC1$18
Corium, LLC2$17
Supernus Pharmaceuticals, Inc.1$17

How this compares

$148,007 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$72,490
Medicare patients
304
Services billed
3,408

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Cordova

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →